SCHEMBL6983377

SCHEMBL6983377

COc1cccc2c3cccc4c3n(c12)CCC4=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.50
MEN1 O00255 3/20 0.50
USP2 O75604 1/20 0.50
S100A4 P26447 1/20 0.50
PRMT1 Q99873 1/20 0.46
ALDH1A1 P00352 7/20 0.44
KDM4E B2RXH2 6/20 0.44
MAPT P10636 4/20 0.44
HTT P42858 3/20 0.44
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.44
PABPC1 P11940 1/20 0.44
XBP1 P17861 1/20 0.44
NFKB1 P19838 1/20 0.44
SMARCA2 P51531 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
CYP19A1 P11511 1/20 0.42
NQO2 P16083 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6982969 0.83 KMT2A (0.46) KMT2AMEN1USP2S100A4PRMT1
SCHEMBL6983511 0.77 TUBB4A (0.42) KMT2AMEN1ALDH1A1KDM4EMAPT
SCHEMBL6981939 0.75 PIM1 (0.42) KMT2AMEN1ALDH1A1KDM4EMAPT
SCHEMBL13851541 0.74 MEN1 (0.61) KMT2AMEN1USP2S100A4ALDH1A1
SCHEMBL6979132 0.72 KMT2A (0.43) KMT2AMEN1USP2S100A4PRMT1
SCHEMBL9258757 0.71 TNFRSF1A (0.43) KMT2AMEN1USP2S100A4ALDH1A1
SCHEMBL7005451 0.70 HTR3A (0.36) KMT2AMEN1ALDH1A1KDM4EMAPT
SCHEMBL7670693 0.70 SMARCA4 (0.41) ALDH1A1KDM4EPABPC1HSD17B10HPGD
SCHEMBL6977937 0.69 MEN1 (0.40) KMT2AMEN1USP2ALDH1A1KDM4E
SCHEMBL6982876 0.69 MAPT (0.36) KMT2AMEN1USP2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0985671-B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARM CO LTD (JP) 2003-04-02 EP disclosed
US-6197768-B1 THERAPY, PREVENTION ISCHEMIC HEART DISEASE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-0985671-A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-03-15 EP disclosed
US-6018046-A SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed